Indian pharmaceutical companies are investing in digital technologies and artificial intelligence (AI) to boost efficiency, help patients and strengthen themselves in the global market, say industry insiders.
Machine learning (ML), the Internet of Things (IoT), the concept of connecting devices to the internet, automation, and predictive maintenance systems are technologies attracting investments.
Dr Reddy’s Laboratories (DRL) said it is integrating digital therapeutics – direct interventions to patients through evidence-based, clinically evaluated software for disease management – into its business model. Nerivio, the company’s drug-free migraine management device, will be sold in Europe and South Africa.
Pharma companies step up use of advanced technologies to improve processes
- Blog